2011 柳叶刀Spinal_cord_injury_time_to_move.1.pdf

2011 柳叶刀Spinal_cord_injury_time_to_move.1.pdf

  1. 1、本文档共4页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
2011 柳叶刀Spinal_cord_injury_time_to_move.1

Comment Finally, as Belch and colleagues conclude, the 3 Ruff olo AJ, Romano M, Ciapponi A. Prostanoids for critical limb ischaemia. absence of benefi t in gene therapy trials might indicate Cochrane Database Syst Rev 2010; 1: CD006544. 4 Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis challenges “to defi ne the optimum dose, vector, route, after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996; 348: 370–74. and duration of administration” and the need for 5 Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy multiple interventions. Perhaps, in our enthusiasm to in peripheral artery disease: a critical appraisal. Thromb Haemost 2010; 103: 696–709. fi nd an eff ective gene therapy for critical limb ischaemia, 6 Collinson DJ, Donnelly R. Therapeutic angiogenesis in peripheral arterial we have neglected to fully understand the basics before disease: can biotechnology produce an eff ective coll

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档